- Home
- / Ambagon Therapeutics
Ambagon Therapeutics
Total Funding
$92.2 M
Ambagon Therapeutics Summary
Company Summary
- Overview
- Ambagon Therapeutics is a biotechnology company discovering and developing small molecule cancer drugs. It stabilizes the interaction of oncogenic proteins with 14-3-3 adaptor proteins. The company provides a platform approach addressing the clinical needs beyond oncology.
- Type
- Private
- Status
- Active
- Founded
- 2020
- HQ
- San Carlos, CA, US | view all locations
- Website
- https://www.ambagontx.com/
- Cybersecurity rating
Table of Contents
LocationsView all
2 locations detected
San Carlos, CA HQ
United States
733 Industrial Rd
Eindhoven, NB
Netherlands
De Lismortel 31
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026